Table 1 Patients' characteristics
From: Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
Patients | Risk group | N-myc amplification | Ploidy | Stage | Shimada | Agae (m) | Sex |
|---|---|---|---|---|---|---|---|
2 | HR | Unknown | Unknown | 4 | UF | 59 | M |
3 | HR | No | > 1 | 4 | UF | 54 | M |
4 | HR | Yes | > 1 | 4 | F | 22 | F |
15 | HR | Yes | > 1 | 3 | UF | 114 | F |
10 | HR | Yes | 1 | 4 | UF | 24 | M |
13 | HR | No | > 1 | 3 | UF | 18 | F |
6 | HR | Yes | 1 | 3 | UF | 55 | M |
17 | HR | Yes | > 1 | 3 | UF | 23 | M |
18 | HR | Yes | 1 | 4 | UF | 20 | M |
1 | LR | No | > 1 | 1 | F | 22 | F |
7 | LR | No | > 1 | 2b | Unknown | 19 | M |
11 | LR | No | > 1 | 4s | F | 5 | M |
12 | LR | No | > 1 | 2b | F | 4 | F |
9 | LR | No | > 1 | 2a | F | 3 | M |
14 | LR | No | > 1 | 1 | Unknown | 6 | M |
5 | LR | Unknown | Unknown | Unknown | Unknown | 28 | F |
16 | LR | No | Unknown | 1 | F | 1 | M |
20 | LR | No | 1 | 2a | F | 41 | M |